CompaniesBiotie Therapies

Biotie Therapies

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (14)
View all

Total Trials

14

As Lead Sponsor

13

As Collaborator

1

Total Enrollment

1,479

By Phase

PHASE1: 6PHASE3: 2PHASE2: 4PHASE2/PHASE3: 1PHASE1/PHASE2: 1

By Status

COMPLETED: 10TERMINATED: 4
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
Today
NCT02258152
NCT02453386
NCT02239211
Hover over trial bars to see details

Recent Trials

NCT03200080Lead Sponsor
A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users
PHASE1Terminated
26 participants
Started: Sep 18, 2017 · Completed: Nov 28, 2017
NCT03212313Lead Sponsor
Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Tozadenant
PHASE1Terminated
20 participants
Started: Jun 30, 2017 · Completed: Dec 31, 2017
NCT03051607Lead Sponsor
Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.
PHASE3Terminated
66 participants
Started: Apr 10, 2017 · Completed: Jan 16, 2018
NCT02239211Collaborator
A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis
PHASE2Completed
23 participants
Started: Sep 8, 2015 · Completed: Oct 23, 2018
NCT02453386Lead Sponsor
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
PHASE3Terminated
449 participants
Started: Jul 31, 2015 · Completed: Jan 12, 2018
View all 14 trials →
Funding History (5)
D
Jun 2, 2015
Filing
DRSLTR
Apr 21, 2015
Filing
DRS/A
Apr 21, 2015
Filing
DRS
Mar 17, 2015
Filing
D
Jun 26, 2013
Filing